Bellerophon Therapeutics Pink Sheet Forecast - Polynomial Regression
| BLPHDelisted Stock | USD 0.71 0.01 1.43% |
The Polynomial Regression forecasted value of Bellerophon Therapeutics on the next trading day is expected to be 3.16 with a mean absolute deviation of 1.05 and the sum of the absolute errors of 63.81. Bellerophon Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Bellerophon Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Bellerophon |
Bellerophon Therapeutics Polynomial Regression Price Forecast For the 13th of December 2024
Given 90 days horizon, the Polynomial Regression forecasted value of Bellerophon Therapeutics on the next trading day is expected to be 3.16 with a mean absolute deviation of 1.05, mean absolute percentage error of 1.78, and the sum of the absolute errors of 63.81.Please note that although there have been many attempts to predict Bellerophon Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Bellerophon Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Bellerophon Therapeutics Pink Sheet Forecast Pattern
| Backtest Bellerophon Therapeutics | Bellerophon Therapeutics Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Bellerophon Therapeutics pink sheet data series using in forecasting. Note that when a statistical model is used to represent Bellerophon Therapeutics pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.6865 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.0461 |
| MAPE | Mean absolute percentage error | 0.9596 |
| SAE | Sum of the absolute errors | 63.8099 |
Predictive Modules for Bellerophon Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bellerophon Therapeutics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Bellerophon Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bellerophon Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Bellerophon Therapeutics could also be used in its relative valuation, which is a method of valuing Bellerophon Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Bellerophon Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Bellerophon Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bellerophon Therapeutics shares will generate the highest return on investment. By undertsting and applying Bellerophon Therapeutics pink sheet market strength indicators, traders can identify Bellerophon Therapeutics entry and exit signals to maximize returns.
Bellerophon Therapeutics Risk Indicators
The analysis of Bellerophon Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Bellerophon Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bellerophon pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.45 | |||
| Standard Deviation | 12.01 | |||
| Variance | 144.28 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Bellerophon Pink Sheet
If you are still planning to invest in Bellerophon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellerophon Therapeutics' history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |